- 专利标题： Compounds for the Treatment of Hepatitis C
-
申请号： US12434748申请日： 2009-05-04
-
公开(公告)号： US20090280083A1公开(公告)日： 2009-11-12
- 发明人: Scott W. Martin , Carl P. Bergstrom , Min Ding , Xiaofan Zheng , Robert G. Gentles
- 申请人： Scott W. Martin , Carl P. Bergstrom , Min Ding , Xiaofan Zheng , Robert G. Gentles
- 专利权人： Bristol-Myers Squibb Company
- 当前专利权人： Bristol-Myers Squibb Company
- 主分类号： A61K31/55
- IPC分类号： A61K31/55 ; C07D405/14 ; A61K38/20 ; A61K38/21 ; A61K38/13 ; A61P31/14 ; C07D417/14 ; C07D405/04
摘要：
The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
公开/授权文献
- US08133884B2 Compounds for the treatment of hepatitis C 公开/授权日：2012-03-13